Tonix Pharmaceuticals Holding (TNXP) Change in Acquisitions & Divestments (2016)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Change in Acquisitions & Divestments came in at $4.8 million in Q1 2016.
Tonix Pharmaceuticals Holding (TNXP) Change in Acquisitions & Divestments (2016) Analysis & Trends
Tonix Pharmaceuticals Holding's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $4.8 million for Q1 2016.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $4.8 million in Q1 2016; TTM through Dec 2017 was $4.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $853000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments was little changed at $4.8 million in Q1 2016 per TNXP's latest filing.
- Across five years, Change in Acquisitions & Divestments topped out at $4.8 million in Q1 2016 and bottomed at $4.8 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Tonix Pharmaceuticals Holding | 141.18 Mn | 141.18 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 4.78 Mn |
| Mar 31, 2016 | 4.78 Mn |